← IPO Calendar

Integris Medtech IPO IPO

Mainline[.][.]
1
Open
[.]
2
Close
[.]
3
Allotment
4
Listing
[.]
Listing Date
[.]
✦ AI Insight

Restated Financials (₹ Cr.)

Period Ended30 Jun 202531 Mar 202531 Mar 202431 Mar 2023
Assets4,019.623,641.342,989.202,553.87
Total Income508.931,959.581,582.261,369.66
Profit After Tax267.5770.68-4.88-40.54
EBITDA78.73309.40190.45168.82
NET Worth3,889.992,752.522,681.022,629.52
Reserves and Surplus2,299.841,150.741,135.711,073.12
Total Borrowing793.421,729.46813.10556.54
Amount in ₹ Crore

Peer Comparison

CompanyIssue TypeIssue SizeIssue PricePE RatioListing Day CloseListing Gain/Loss %LTP
Molbio Diagnostics Ltd.Mainboard₹939.70 Cr₹80755.43₹1,041.70+29.08%₹1,438.20
Fabtech Technologies Ltd.Mainboard₹230.30 Cr₹19113.32₹182.40-4.50%₹147.02
Q-Line Biotech Ltd.SME₹214.48 Cr₹34320.82₹474.60+38.37%₹726.20
Earkart Ltd.SME₹49.26 Cr₹13520.48₹142.25+5.37%₹127.05

Objects of the Issue

#Issue ObjectsEst Amt (₹ Cr.)
1Repayment/ prepayment, in full or in part, of certain outstanding borrowings, interest accrued and prepayment penalties, as applicable, availed by:696.39
2The wholly-owned Subsidiaries, namely, Translumina Therapeutics Private Limited (“Translumina Therapeutics”), Transhealth Private Limited (“Transhealth”) ”) and HaleMed Medical Private Limited; and125.40
3The step-down Subsidiaries, namely, CPC Diagnostics Private Limited, Chemopharm Sdn. Bhd., Chemoscience Pte Ltd., Lifeline Diagnostics Supplies Inc., Hausen Bernstein Co. Ltd, Medigene Sdn. Bhd., Research Instruments Sdn Bhd and Research Instruments Pte. Ltd.571.00
4General corporate purposes

About Integris Medtech IPO

Updated on Jun 22, 2026

Contact Details

Integris Medtech Ltd. Address1 st FloorMetro Tower LSCM.O.R Land, New Rajinder NagarNorth Delhi, New Delhi, 110060+91 120 4531422investors@integrismedtech.comVisit Website